MYD88 and TLR2, in the core enrichment gene list of inflammatory response signaling, was previously reported to be associated with low-risk MDS, while downregulated in high-risk MDS (Dimicoli et al., 2013; Wei et al., 2013). This evidence concerns the gene TLR2 and myelodysplastic syndrome.